TY  - JOUR
AU  - Quiroga, Borja
AU  - Soler, María José
AU  - Ortiz, Alberto
AU  - Martínez Vaquera, Shaira
AU  - Jarava Mantecón, Carlos Jesús
AU  - Useche, Gustavo
AU  - Sánchez Márquez, María Gabriela
AU  - Carnerero, Manuel
AU  - Jaldo Rodríguez, María Teresa
AU  - Muñoz Ramos, Patricia
AU  - Ruiz San Millán, Juan Carlos
AU  - Toapanta, Nestor
AU  - Gracia-Iguacel, Carolina
AU  - Aguilar Cervera, María Cinta
AU  - Balibrea Lara, Noelia
AU  - Leyva, Alba
AU  - Rojas, José
AU  - Gansevoort, Ron T
AU  - de Sequera, Patricia
AU  - SENCOVAC Collaborative Network
PY  - 2022
DO  - 10.1093/ndt/gfab313
UR  - http://hdl.handle.net/10668/19817
T2  - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
AB  - Chronic kidney disease (CKD) patients are at high-risk for severe coronavirus disease 2019 (COVID-19). The multicentric, observational and prospective SENCOVAC study aims to describe the humoral response and safety of severe acute respiratory syndrome...
LA  - en
KW  - COVID-19
KW  - SARS-CoV-2
KW  - antibodies
KW  - humoral response
KW  - vaccine
KW  - Antibodies, Viral
KW  - BNT162 Vaccine
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Humans
KW  - Prospective Studies
KW  - Renal Insufficiency, Chronic
KW  - SARS-CoV-2
TI  - Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
TY  - research article
VL  - 37
ER  -